GlassScriptPhysician profile
Theresa E Cohen
NPI 1083633622
$1,037.74
in general payments reported to CMS, 2019-2025
18 companies · $741 in 2025
The $741 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $82.57 · 2023: $214 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $169.08 | 2023-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Abbott Laboratories | $102.31 | 2022-2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $94.12 | 2025 | Zoryve |
| Novo Nordisk INC | $73.75 | 2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $70.51 | 2025 | Farxiga |
| Abbvie INC. | $68.14 | 2025 | |
| Grifols USA, LLC | $66.25 | 2023 | Hyperrab |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $61.73 | 2025 | Caplyta |
| Ardelyx, INC. | $57.70 | 2025 | Ibsrela |
| Otsuka America Pharmaceutical, INC. | $45.22 | 2025 | Rexulti |
| Amgen INC. | $44.55 | 2025 | Otezla, Repatha |
| Pfizer INC. | $37.41 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.22 | 2025 | Jardiance |
| Viiv Healthcare Company | $27.27 | 2025 | Apretude |
| Phathom Pharmaceuticals, INC. | $26.28 | 2025 | Voquezna |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $22.12 | 2025 | Nucala |
| Phadia US INC. | $19.42 | 2025 | Immunocap |
| Bayer Healthcare Pharmaceuticals INC. | $16.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theresa Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.